Chapter 1. Preface
1.1. Report Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Market Segmentation
1.3. Research Scope
1.4. Research Methodology
1.4.1. Phase I – Secondary Research
1.4.2. Phase II – Primary Research
1.4.3. Phase III – Expert Panel Review
1.4.4. Assumptions
1.5. Market Segmentation
Chapter 2. Executive Summary
2.1. Global Neuroprosthetics Market Portraiture
2.2. Global Neuroprosthetics Market, by Type, 2017 (US$ Bn)
2.3. Global Neuroprosthetics Market, by Modality, 2017 (US$ Bn)
2.4. Global Neuroprosthetics Market, by Application, 2017 (US$ Bn)
2.5. Global Neuroprosthetics Market, by Geography, 2017 (US$ Bn)
Chapter 3. Global Neuroprosthetics Market: Dynamics and Future Outlook
3.1. Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global Neuroprosthetics Market, by Key Players, 2017
Chapter 4. Global Neuroprosthetics Market, by Type, 2016-2026 (US$ Bn)
4.1. Overview
4.2. Motor Prosthetics
4.3. Auditory Prosthetics
4.4. Cognitive Prosthetics
4.5. Visual Prosthetics
Chapter 5. Global Neuroprosthetics Market, by Modality, 2016-2026 (US$ Bn)
5.1. Overview
5.2. Deep Brain Stimulation (DBS)
5.3. Vagus Nerve Stimulation (VNS)
5.4. Spinal Cord Stimulation (SCS)
5.5. Sacral Nerve Stimulation (SNS)
5.6. Others
Chapter 6. Global Neuroprosthetics Market, by Application, 2016-2026 (US$ Bn)
6.1. Overview
6.2. Motor Neuron Disorders
6.2.1. Parkinson’s Disease
6.2.2. Epilepsy
6.3. Physiological Disorders
6.3.1. Auditory Disorders
6.3.2. Cardiac Disorders
6.3.3. Chronic Pain
6.3.4. Others (Ophthalmic and Kidney Disorders)
6.4. Cognitive Disorders
6.4.1. Alzheimer’s Disease
6.4.2. Severe Depression
Chapter 7. Global Neuroprosthetics Market, by Geography, 2016 – 2026 (US$ Bn)
7.1. Overview
7.1.1. North America Neuroprosthetics Market, 2016-2026 (US$ Bn)
7.1.2. North America Neuroprosthetics Market, by Type, 2016 – 2026 (US$ Bn)
7.1.3. North America Neuroprosthetics Market, by Modality, 2016 – 2026 (US$ Bn)
7.1.4. North America Neuroprosthetics Market, by Application, 2016 – 2026 (US$ Bn)
7.1.5. North America Neuroprosthetics Market, by Country, 2016 – 2026 (US$ Bn)
7.1.5.1. U.S.
7.1.5.2. Canada
7.2. Europe Neuroprosthetics Market, 2016 – 2026 (US$ Bn)
7.2.1. Europe Neuroprosthetics Market, by Type, 2016 – 2026 (US$ Bn)
7.2.2. Europe Neuroprosthetics Market, by Modality, 2016 – 2026 (US$ Bn)
7.2.3. Europe Neuroprosthetics Market, by Application, 2016 – 2026 (US$ Bn)
7.2.4. Europe Neuroprosthetics Market, by Country/Region, 2016 – 2026 (US$ Bn)
7.2.4.1. U.K.
7.2.4.2. Germany
7.2.4.3. Rest of Europe
7.3. Asia Pacific Neuroprosthetics Market, 2016 – 2026 (US$ Bn)
7.3.1. Asia Pacific Neuroprosthetics Market, by Type, 2016 – 2026 (US$ Bn)
7.3.2. Asia Pacific Neuroprosthetics Market, by Modality, 2016 – 2026 (US$ Bn)
7.3.3. Asia Pacific Neuroprosthetics Market, by Application, 2016 – 2026 (US$ Bn)
7.3.4. Asia Pacific Neuroprosthetics Market, by Country/Region, 2016 – 2026 (US$ Bn)
7.3.4.1. China
7.3.4.2. Japan
7.3.4.3. Rest of Asia Pacific
7.4. Latin America Neuroprosthetics Market, 2016 – 2026 (US$ Bn)
7.4.1. Latin America Neuroprosthetics Market, by Type, 2016 – 2026 (US$ Bn)
7.4.2. Latin America Neuroprosthetics Market, by Modality, 2016 – 2026 (US$ Bn)
7.4.3. Latin America Neuroprosthetics Market, by Application, 2016 – 2026 (US$ Bn)
7.4.4. Latin America Neuroprosthetics Market, by Country/Region, 2016 – 2026 (US$ Bn)
7.4.4.1. Brazil
7.4.4.2. Mexico
7.4.4.3. Rest of Latin America
7.5. Middle East & Africa Neuroprosthetics Market, 2016 – 2026 (US$ Bn)
7.5.1. Middle East & Africa Neuroprosthetics Market, by Type, 2016 – 2026 (US$ Bn)
7.5.2. Middle East & Africa Neuroprosthetics Market, by Modality, 2016 – 2026 (US$ Bn)
7.5.3. Middle East & Africa Neuroprosthetics Market, by Application, 2016 – 2026 (US$ Bn)
7.5.4. Middle East & Africa Neuroprosthetics Market, by Region, 2016 – 2026 (US$ Bn)
7.5.4.1. GCC
7.5.4.2. Rest of Middle East & Africa
Chapter 8. Company Profiles
8.1. Abbott Laboratories
8.1.1. Business Description
8.1.2. Financial Information (Subject to Data Availability)
8.1.3. Product Portfolio
8.1.4. Key Developments
8.2. Boston Scientific Corporation
8.3. Cochlear Limited
8.4. LivaNova, PLC
8.5. MED-EL
8.6. Medtronic Plc
8.7. NDI Medical LLC
8.8. NeuroPace, Inc.
8.9. Nervo Corp.
8.10. Retina Implant AG
8.11. Second Sight Medical Products, Inc.
8.12. Sonova Holding AG
8.13. Cyberonics, Inc.
8.14. St. Jude Medical, Inc.
8.15. BrainGate Company
List of Figures
FIG 1. Neuroprosthetics Market: Research Methodology
FIG 2. Neuroprosthetics: Market Segmentation
FIG 3. Global Neuroprosthetics Market, by Type, 2017 (US$ Bn)
FIG 4. Global Neuroprosthetics Market, by Modality, 2017 (US$ Bn)
FIG 5. Global Neuroprosthetics Market, by Application, 2017 (US$ Bn)
FIG 6. Global Neuroprosthetics Market, by Geography, 2017 (US$ Bn)
FIG 7. Attractive Investment Proposition, by Geography, 2017
FIG 8. Competitive Analysis: Global Neuroprosthetics Market, by Key Players, 2017
FIG 9. Global Motor Prosthetics Market, 2016-2026(US$ Bn)
FIG 10. Global Auditory Prosthetics Market, 2016-2026 (US$ Bn)
FIG 11. Global Cognitive Prosthetics Market, 2016-2026 (US$ Bn)
FIG 12. Global Visual Prosthetics Market, 2016-2026 (US$ Bn)
FIG 13. Global Deep Brain Stimulation (DBS) Neuroprosthetics Market, 2016-2026 (US$ Bn)
FIG 14. Global Neuroprosthetics Vagus Nerve Stimulation (VNS) Market, 2016-2026 (US$ Bn)
FIG 15. Global Neuroprosthetics Spinal Cord Stimulation (SCS) Market, 2016-2026 (US$ Bn)
FIG 16. Global Neuroprosthetics Sacral Nerve Stimulation (SNS) Market, 2016-2026 (US$ Bn)
FIG 17. Global Neuroprosthetics Market for Parkinson’s Disease, 2016-2026 (US$ Bn)
FIG 18. Global Neuroprosthetics Market for Epilepsy, 2016-2026 (US$ Bn)
FIG 19. Global Neuroprosthetics Market for Auditory Disorders, 2016-2026 (US$ Bn)
FIG 20. Global Neuroprosthetics Market for Cardiac Disorders, 2016-2026 (US$ Bn)
FIG 21. Global Neuroprosthetics Market for Chronic Pain, 2016-2026 (US$ Bn)
FIG 22. Global Neuroprosthetics Market for Other Physiological Disorders, 2016-2026 (US$ Bn)
FIG 23. Global Neuroprosthetics Market for Alzheimer’s Disease, 2016-2026 (US$ Bn)
FIG 24. Global Neuroprosthetics Market for Severe Depression, 2016-2026 (US$ Bn)
FIG 25. U.S. Neuroprosthetics Market, 2016-2026 (US$ Bn)
FIG 26. Canada Neuroprosthetics Market, 2016-2026 (US$ Bn)
FIG 27. U.K. Neuroprosthetics Market, 2016-2026 (US$ Bn)
FIG 28. Germany Neuroprosthetics Market, 2016-2026 (US$ Bn)
FIG 29. Rest of Europe Neuroprosthetics Market, 2016-2026 (US$ Bn)
FIG 30. China Neuroprosthetics Market, 2016-2026 (US$ Bn)
FIG 31. Japan Neuroprosthetics Market, 2016-2026 (US$ Bn)
FIG 32. Rest of Asia Pacific Neuroprosthetics Market, 2016-2026 (US$ Bn)
FIG 33. Brazil Neuroprosthetics Market, 2016-2026 (US$ Bn)
FIG 34. Mexico Neuroprosthetics Market, 2016-2026 (US$ Bn)
FIG 35. Rest of Latin America Neuroprosthetics Market, 2016-2026 (US$ Bn)
FIG 36. GCC Neuroprosthetics Market, 2016-2026 (US$ Bn)
FIG 37. Rest of Middle East and Africa Neuroprosthetics Market, 2016-2026 (US$ Bn)
List of Tables
TABLE 1 Global Neuroprosthetics Market Portraiture
TABLE 2 Global Neuroprosthetics Market, by Type, 2016 – 2026 (US$ Bn)
TABLE 3 Global Neuroprosthetics Market, by Modality, 2016 – 2026 (US$ Bn)
TABLE 4 Global Neuroprosthetics Market, by Application, 2016 – 2026 (US$ Bn)
TABLE 5 Global Neuroprosthetics for Motor Neuron Disorders Market, by Type, 2016 – 2026 (US$ Bn)
TABLE 6 Global Neuroprosthetics for Physiological Disorders Market, by Type, 2016 – 2026 (US$ Bn)
TABLE 7 Global Neuroprosthetics for Cognitive Disorders Market, by Type, 2016 – 2026 (US$ Bn)
TABLE 8 North America Neuroprosthetics Market, by Type, 2016 – 2026 (US$ Bn)
TABLE 9 North America Neuroprosthetics Market, by Modality, 2016 – 2026 (US$ Bn)
TABLE 10 North America Neuroprosthetics Market, by Application, 2016 – 2026 (US$ Bn)
TABLE 11 North America Neuroprosthetics Market, by Country, 2016 – 2026 (US$ Bn)
TABLE 12 Europe Neuroprosthetics Market, by Type, 2016 – 2026 (US$ Bn)
TABLE 13 Europe Neuroprosthetics Market, by Modality, 2016 – 2026 (US$ Bn)
TABLE 14 Europe Neuroprosthetics Market, by Application, 2016 – 2026 (US$ Bn)
TABLE 15 Europe Neuroprosthetics Market, by Country/Region, 2016 – 2026 (US$ Bn)
TABLE 16 Asia Pacific Neuroprosthetics Market, by Type, 2016 – 2026 (US$ Bn)
TABLE 17 Asia Pacific Neuroprosthetics Market, by Modality, 2016 – 2026 (US$ Bn)
TABLE 18 Asia Pacific Neuroprosthetics Market, by Application, 2016 – 2026 (US$ Bn)
TABLE 19 Asia Pacific Neuroprosthetics Market, by Country/Region, 2016 – 2026 (US$ Bn)
TABLE 20 Latin America Neuroprosthetics Market, by Type, 2016 – 2026 (US$ Bn)
TABLE 21 Latin America Neuroprosthetics Market, by Modality, 2016 – 2026 (US$ Bn)
TABLE 22 Latin America Neuroprosthetics Market, by Application, 2016 – 2026 (US$ Bn)
TABLE 23 Latin America Neuroprosthetics Market, by Country/Region, 2016 – 2026 (US$ Bn)
TABLE 24 Middle East and Africa Neuroprosthetics Market, by Type, 2016 – 2026 (US$ Bn)
TABLE 25 Middle East and Africa Neuroprosthetics Market, by Modality, 2016 – 2026 (US$ Bn)
TABLE 26 Middle East and Africa Neuroprosthetics Market, by Application, 2016 – 2026 (US$ Bn)
TABLE 27 Middle East and Africa Neuroprosthetics Market, by Region, 2016 – 2026 (US$ Bn)
TABLE 28 Abbott Laboratories: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 29 Boston Scientific Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 30 Cochlear Limited: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 31 LivaNova, PLC: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 32 MED-EL: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 33 Medtronic Plc: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 34 NDI Medical LLC: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 35 NeuroPace, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 36 Nervo Corp.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 37 Retina Implant AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 38 Second Sight Medical Products, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 39 Sonova Holding AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 40 Cyberonics, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 41 St. Jude Medical, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 42 BrainGate Company: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)